Japanese Industrials Stock News

TSE:5332
TSE:5332Building

Is It Too Late To Consider TOTO (TSE:5332) After Its 59.9% One-Year Rally?

If you are wondering whether TOTO is priced attractively right now, the key question is how its current share price compares with its underlying worth. The stock last closed at JP¥5,421, and its returns over 1 year sit at 59.9%, with 23.6% year to date, 27.9% over 3 years, 6.6% over 5 years, 0.7% over 7 days, and a 0.1% decline over 30 days, which can change how investors think about both opportunity and risk. Recent news coverage has focused on TOTO in the context of broader market interest...
TSE:8750
TSE:8750Insurance

Is It Time To Reassess Daiichi Life Group (TSE:8750) After Japan Governance Reforms?

If you are wondering whether Daiichi Life Group's current share price reflects its underlying value, this article walks through what the numbers are really saying about the stock. The share price most recently closed at ¥1,410.5, with returns of 5.7% year to date and 48.6% over 1 year. Meanwhile, the 7 day and 30 day returns of a 3.4% decline and a 1.9% decline hint at a more mixed short term picture. Recent coverage has focused on Daiichi Life Group's role within the Japanese insurance...
TSE:6645
TSE:6645Electronic

Is It Too Late To Consider OMRON (TSE:6645) After Its Recent Share Price Rebound?

If you are wondering whether OMRON is priced attractively right now, the recent share performance and a mixed valuation picture make it a stock worth a closer look. The share price closed at ¥5,093, with returns of 1.9% over 7 days, 13.0% over 30 days, 27.5% year to date and 21.5% over 1 year. This compares with declines of 31.8% over 3 years and 33.1% over 5 years. Recent news around OMRON has focused on the company as a key name in Japan's technology sector. This helps frame how investors...
TSE:3407
TSE:3407Chemicals

Asahi Kasei Expands Pharma Reach With Aicuris Deal And AK1940 Trial

Asahi Kasei (TSE:3407) has completed its acquisition of German biopharmaceutical company Aicuris Anti-infective Cures. The company has also initiated a Phase I clinical trial for AK1940, a new therapy candidate for autoimmune diseases. Both developments mark a shift in focus toward infectious and autoimmune disease treatments within Asahi Kasei's pharmaceutical operations. Asahi Kasei, traditionally known for chemicals, materials, and health care businesses, is steadily building out its...
TSE:7912
TSE:7912Commercial Services

How Investors May Respond To Dai Nippon Printing (TSE:7912) Expanding Its Advanced Automotive Display Films

Dai Nippon Printing Co., Ltd. has announced it will begin mass production in April 2026 of a new decorative film for automotive displays that combines woodgrain-style design with advanced optical performance, initially targeting the Chinese market before moving into Europe, Japan, the United States, South Korea, India and other regions. An interesting angle is DNP’s plan to apply this microfabricated, Electron Beam-coated film beyond car interiors, including exterior auto components and...
TSE:8015
TSE:8015Trade Distributors

Is It Too Late To Consider Toyota Tsusho (TSE:8015) After Its 143% One Year Surge?

If you are wondering whether Toyota Tsusho at ¥6,100 still offers value, the key is understanding how its current price lines up with different valuation checks. The stock is up 10.8% year to date, with a 142.7% return over the past year, even though the last 7 and 30 days show modest declines of 2.3% and 2.1%. Recent coverage has focused on Toyota Tsusho as part of broader discussions around major Japanese trading houses and their roles in global supply chains, resource sourcing, and...
TSE:7261
TSE:7261Auto

Mazda’s Indiana Transmission Shift And What It May Mean For Valuation

Aisin has begun contract manufacturing Mazda Motor's six speed automatic transmission in Indiana. The new production is aimed at improving Mazda's transmission supply and responsiveness within North America. This move expands Mazda's manufacturing footprint closer to its key regional customers. Mazda Motor (TSE:7261) is drawing fresh attention with this new North American transmission production, coming at a time when the shares trade at ¥1,058.0. The stock has seen a 30.4% gain over the...
TSE:4755
TSE:4755Multiline Retail

Is Rakuten Group (TSE:4755) Offering Value After Telecom Reorganization And Mixed Returns?

Wondering whether Rakuten Group at around ¥795.8 is offering value or just noise? This breakdown helps you connect the share price to what the underlying business may be worth. Over the past week the stock returned 0.6%. Over the last month it returned 9.3%. Year to date it shows a 20.7% decline and a 44.6% decline over five years, with a 3.3% return across the last year and 18.8% across three years. Recent coverage around Rakuten Group has focused on its position as a major Japanese retail...
TSE:3157
TSE:3157Trade Distributors

Global Dividend Stocks To Watch In April 2026

As global markets experience a wave of optimism driven by Middle East de-escalation and strong earnings reports, investors are eyeing opportunities in dividend stocks that can offer stability amid fluctuating economic conditions. In such an environment, a good dividend stock typically combines consistent payout history with robust financial health, providing potential resilience against market volatility.
TSE:4480
TSE:4480Healthcare Services

3 Asian Stocks That May Be Trading Below Their Estimated Intrinsic Values

Amidst a backdrop of geopolitical developments and economic data releases, Asian markets have shown resilience, with indices in Japan and China experiencing gains driven by optimism around diplomatic progress and robust economic figures. In this environment, identifying stocks that may be trading below their estimated intrinsic values can present opportunities for investors looking to capitalize on potential market inefficiencies.
TSE:7157
TSE:7157Insurance

A Look At Lifenet Insurance (TSE:7157) Valuation After Strong March 2026 Premium Growth

Lifenet Insurance (TSE:7157) has released preliminary premium figures for March 2026, putting fresh attention on how its book of in force policies is shaping up across key product lines. See our latest analysis for Lifenet Insurance. The fresh premium data arrives after a period where momentum has been gradually building, with a 12.98% year to date share price return and a 3-year total shareholder return of 85.48% highlighting how the market has been reassessing Lifenet Insurance over...